New 52 Week High Today

BioNTech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:59 PM EDT
282.00quote price arrow up+0.04 (+0.01%)
Volume
24,277
Close
281.96quote price arrow up+0.98 (+0.35%)
Volume
4,294,480
52 week range
54.10 - 292.33

...

Loading . . .
  • Open287.03
  • Day High292.33
  • Day Low267.03
  • Prev Close280.98
  • 52 Week High292.33
  • 52 Week High Date07/23/21
  • 52 Week Low54.10
  • 52 Week Low Date09/04/20

Key Stats

  • Market Cap68.099B
  • Shares Out241.52M
  • 10 Day Average Volume3.71M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change245.88

KEY STATS

  • Open287.03
  • Day High292.33
  • Day Low267.03
  • Prev Close280.98
  • 52 Week High292.33
  • 52 Week High Date07/23/21
  • 52 Week Low54.10
  • 52 Week Low Date09/04/20
  • Market Cap68.099B
  • Shares Out241.52M
  • 10 Day Average Volume3.71M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change245.88

RATIOS/PROFITABILITY

  • EPS (TTM)5.33
  • P/E (TTM)52.87
  • Fwd P/E (NTM)7.87
  • EBITDA (MRQ)1.98B
  • ROE (MRQ)80.65%
  • Revenue (MRQ)2.946B
  • Gross Margin (MRQ)88.55%
  • Net Margin (MRQ)47.81%
  • Debt To Equity (MRQ)23.21%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
495.51+8.99+1.85%
GMAB
Genmab A/S
44.85+0.49+1.10%
INCY
Incyte Corp
79.30+0.68+0.86%
CRL
Charles River Laboratories International Inc
396.32+3.07+0.78%
EXAS
Exact Sciences Corp
117.95-0.08-0.07%